Skip to Content Skip to Navigation

Return to work, safely

Emerald is at the forefront of designing evidence-based healthcare models. During the COVID-19 pandemic, our team has been working closely with world-class partners in medical technology – including Mt Sinai, The University of Sydney and – to incorporate intelligent symptom and vital signs monitoring into the Emerald Real-World Evidence Platform. Our system is unique in that it is monitored by clinicians and purpose-built to help businesses and industries keep their people safe.

It works by securely, privately and intelligently monitoring the symptoms and vital signs of participants. Our team of clinicians monitor all responses and an AI-driven alerting system flags people requiring further follow-up by one of our doctors.

This service keeps your people safe in an uncertain time, compliments current testing programs and can help guard against a second wave or the next pandemic.

We are now welcoming partnerships with businesses and institutions who would like to work with us and help protect the health of their people. We are mobilised to deploy the app within workforce populations of up to thousands of people across Australia.

Emerald is a program manager for the national Clinical Data and Analytics Platform (CDAP) of COVID-19 patient cases – a partnership initiated between Australian state health bodies, the Federal Government and universities. So, if you innovate with us, you can be assured of working with an endorsed provider of the highest quality health data systems in Australia.

Register your interest now.